Last reviewed · How we verify

NeoMTA

Texas A & M University Baylor College Of Dentistry · FDA-approved active Biologic

NeoMTA is a bioactive dental material that promotes mineralization and biocompatibility through calcium and hydroxide ion release.

NeoMTA is a bioactive dental material that promotes mineralization and biocompatibility through calcium and hydroxide ion release. Used for Endodontic applications including pulp capping and apical barrier formation, Periapical lesion treatment, Root perforation repair.

At a glance

Generic nameNeoMTA
SponsorTexas A & M University Baylor College Of Dentistry
Drug classDental biomaterial / Bioactive cement
ModalityBiologic
Therapeutic areaDentistry / Endodontics
PhaseFDA-approved

Mechanism of action

NeoMTA is a nanoparticle-modified mineral trioxide aggregate (MTA) formulation designed for endodontic and restorative dental applications. It combines the bioactive properties of traditional MTA with improved handling characteristics and enhanced biocompatibility. The material releases calcium ions that promote remineralization and create an alkaline environment conducive to healing.

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results